{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:38:37Z","timestamp":1777606717145,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>The aim<\/jats:title>\n                    <jats:p>\n                      To investigate the role of Sirtuin 1 (SIRT1) level and\n                      <jats:italic>SIRT1<\/jats:italic>\n                      (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n\u2009=\u200930) and patients without MS (n\u2009=\u200943). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program \"IBM SPSS Statistics 27.0\".<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We discovered that\n                      <jats:italic>SIRT1<\/jats:italic>\n                      rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p\u2009=\u20090.007), dominant (p\u2009=\u20090.011), and over-dominant (p\u2009=\u20090.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p\u2009=\u20090.010), twofold increased odds under the over-dominant (p\u2009=\u20090.032) models and a 1.2-fold increased odds of ON with MS development (p\u2009=\u20090.015) under the additive model. We also discovered that the\n                      <jats:italic>SIRT1<\/jats:italic>\n                      rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p\u2009=\u20090.001), dominant (p\u2009=\u20090.006), and over-dominant (p\u2009&lt;\u20090.001) models, and a fourfold increased odds of ON with MS development under the codominant (p\u2009&lt;\u20090.001), dominant (p\u2009=\u20090.001), over-dominant (p\u2009&lt;\u20090.001) models and with a twofold increased odds of ON with MS development (p\u2009=\u20090.013) under the additive genetic model. There was no association between SIRT1 levels and ON with\/without MS development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SIRT1<\/jats:italic>\n                      rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02665-x","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T17:15:25Z","timestamp":1679850925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Aleksandra","family":"Kubiliute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-8825","authenticated-orcid":false,"given":"Greta","family":"Gedvilaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvita","family":"Vilkeviciute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loresa","family":"Kriauciuniene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akvile","family":"Bruzaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Zaliuniene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Liutkeviciene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"6","key":"2665_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.21141","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger K. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007;61(6):504\u201313.","journal-title":"Ann Neurol"},{"issue":"10","key":"2665_CR2","first-page":"712","volume":"87","author":"R Nicholas","year":"2013","unstructured":"Nicholas R, Rashid W. Multiple sclerosis. Am Fam Physician. 2013;87(10):712\u20134.","journal-title":"Am Fam Physician"},{"key":"2665_CR3","doi-asserted-by":"crossref","unstructured":"Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008;65(6).","DOI":"10.1001\/archneur.65.6.727"},{"issue":"8","key":"2665_CR4","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1167\/iovs.08-2817","volume":"50","author":"C Jaliffa","year":"2009","unstructured":"Jaliffa C, Ameqrane I, Dansault A, Leemput J, Vieira V, Lacassagne E, et al. Sirt1 involvement in rd10 mouse retinal degeneration. Invest Opthalmol Vis Sci. 2009;50(8):3562.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"3","key":"2665_CR5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1167\/iovs.17-22972","volume":"59","author":"D McDougald","year":"2018","unstructured":"McDougald D, Dine K, Zezulin A, Bennett J, Shindler K. SIRT1 and NRF2 gene transfer mediate distinct neuroprotective effects upon retinal ganglion cell survival and function in experimental optic neuritis. Invest Opthalmol Vis Sci. 2018;59(3):1212.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"3","key":"2665_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12026-014-8557-5","volume":"61","author":"A Martin","year":"2014","unstructured":"Martin A, Tegla C, Cudrici C, Kruszewski A, Azimzadeh P, Boodhoo D, et al. Role of SIRT1 in autoimmune demyelination and neurodegeneration. Immunol Res. 2014;61(3):187\u201397.","journal-title":"Immunol Res"},{"key":"2665_CR7","doi-asserted-by":"crossref","unstructured":"Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan R, Dine K, Dutt M et al. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol. 2012;3.","DOI":"10.3389\/fneur.2012.00084"},{"issue":"1","key":"2665_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.2559","volume":"18","author":"H Jeong","year":"2011","unstructured":"Jeong H, Cohen D, Cui L, Supinski A, Savas J, Mazzulli J, et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med. 2011;18(1):159\u201365.","journal-title":"Nat Med"},{"key":"2665_CR9","doi-asserted-by":"crossref","unstructured":"Khan R, Dine K, Das Sarma J, Shindler K. SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathologica Commun. 2014;2(1).","DOI":"10.1186\/2051-5960-2-3"},{"key":"2665_CR10","doi-asserted-by":"crossref","unstructured":"Khan R, Fonseca-Kelly Z, Callinan C, Zuo L, Sachdeva M, Shindler K. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci. 2012;6.","DOI":"10.3389\/fncel.2012.00063"},{"issue":"13","key":"2665_CR11","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim D, Nguyen M, Dobbin M, Fischer A, Sananbenesi F, Rodgers J, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis. EMBO J. 2007;26(13):3169\u201379.","journal-title":"EMBO J"},{"issue":"9","key":"2665_CR12","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.4049\/jimmunol.1202584","volume":"190","author":"V Nimmagadda","year":"2013","unstructured":"Nimmagadda V, Bever C, Vattikunta N, Talat S, Ahmad V, Nagalla N, et al. Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets. J Immunol. 2013;190(9):4595\u2013607.","journal-title":"J Immunol"},{"issue":"4","key":"2665_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","volume":"30","author":"K Shindler","year":"2010","unstructured":"Shindler K, Ventura E, Dutt M, Elliott P, Fitzgerald D, Rostami A. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010;30(4):328\u201339.","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"2665_CR14","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1167\/iovs.07-0131","volume":"48","author":"K Shindler","year":"2007","unstructured":"Shindler K, Ventura E, Rex T, Elliott P, Rostami A. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Opthalmol Vis Sci. 2007;48(8):3602.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"7","key":"2665_CR15","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1167\/iovs.13-12157","volume":"54","author":"L Zuo","year":"2013","unstructured":"Zuo L, Khan R, Lee V, Dine K, Wu W, Shindler K. SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Opthalmol Vis Sci. 2013;54(7):5097.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2665_CR16","doi-asserted-by":"crossref","unstructured":"Banevicius M., Vilkeviciute A., Glebauskiene B., Kriauciuniene L., Liutkeviciene R. Association of optic neuritis with CYP4F2 gene single nucleotide polymorphism and IL-17A concentration. J Ophthalmol. 2018; 2018.","DOI":"10.1155\/2018\/1686297"},{"key":"2665_CR17","doi-asserted-by":"crossref","unstructured":"Quinn T, Dutt M, Shindler K. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol. 2011;2.","DOI":"10.3389\/fneur.2011.00050"},{"issue":"5","key":"2665_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/1352458506070629","volume":"12","author":"K Shindler","year":"2006","unstructured":"Shindler K, Guan Y, Ventura E, Bennett J, Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult Scler J. 2006;12(5):526\u201332.","journal-title":"Mult Scler J"},{"issue":"9","key":"2665_CR19","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1093\/brain\/awq146","volume":"133","author":"A Henderson","year":"2010","unstructured":"Henderson A, Altmann D, Trip A, Kallis C, Jones S, Schlottmann P, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain. 2010;133(9):2592\u2013602.","journal-title":"Brain"},{"key":"2665_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107846","volume":"98","author":"J Guo","year":"2021","unstructured":"Guo J, Li B, Wang J, Guo R, Tian Y, Song S, et al. Protective effect and mechanism of nicotinamide adenine dinucleotide against optic neuritis in mice with experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2021;98: 107846.","journal-title":"Int Immunopharmacol"},{"key":"2665_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuroscience.2022.01.016","volume":"487","author":"J Guo","year":"2022","unstructured":"Guo J, Wang J, Guo R, Shao H, Guo L. Pterostilbene protects the optic nerves and retina in a murine model of experimental autoimmune encephalomyelitis via activation of SIRT1 signaling. Neuroscience. 2022;487:35\u201346.","journal-title":"Neuroscience"},{"issue":"7","key":"2665_CR22","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1167\/iovs.11-9259","volume":"53","author":"S Balaiya","year":"2012","unstructured":"Balaiya S, Ferguson L, Chalam K. Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Opthalmol Vis Sci. 2012;53(7):4315.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2665_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exer.2013.07.017","volume":"116","author":"T Mimura","year":"2013","unstructured":"Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of SIRT1 in ocular aging. Exp Eye Res. 2013;116:17\u201326.","journal-title":"Exp Eye Res"},{"issue":"3","key":"2665_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13816810.2019.1622022","volume":"40","author":"G Gedvilaite","year":"2019","unstructured":"Gedvilaite G, Vilkeviciute A, Kriauciuniene L, Asmoniene V, Liutkeviciene R. Does CETP rs5882, rs708272, SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, VEGFA rs833068, IL6 rs1800795 polymorphisms play a role in optic neuritis development? Ophthalmic Genet. 2019;40(3):219\u201326.","journal-title":"Ophthalmic Genet"},{"issue":"7","key":"2665_CR25","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1167\/iovs.08-2666","volume":"50","author":"S Kubota","year":"2009","unstructured":"Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor\u2013\u03baB activation. Invest Opthalmol Vis Sci. 2009;50(7):3512.","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"6","key":"2665_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ncb2735","volume":"15","author":"V Rafalski","year":"2013","unstructured":"Rafalski V, Ho P, Brett J, Ucar D, Dugas J, Pollina E, et al. Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat Cell Biol. 2013;15(6):614\u201324.","journal-title":"Nat Cell Biol"},{"key":"2665_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3187594","volume":"2017","author":"S Balaiya","year":"2017","unstructured":"Balaiya S, Abu-Amero K, Kondkar A, Chalam K. Sirtuins expression and their role in retinal diseases. Oxid Med Cell Longev. 2017;2017:1\u201311.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02665-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T17:17:36Z","timestamp":1679851056000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02665-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2665"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02665-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1618512\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kaunas Regional Biomedical Research Ethics Committee approved the study (No. BE-2-13).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study subjects provided written informed consent in accordance with the Declaration of Helsinki. The study was conducted in the Department of Ophthalmology, Hospital of LUHS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any proprietary interests or conflicts of interest related to this submission. This submission has not been previously published anywhere, and it is not simultaneously being considered for any other publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}